Search research articles
Contact Us
Filters
Showing results (81-90 of 97) with videos related to
Page
of 10
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2014
A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer
D J Renouf, P A Tang, D Hedley, et al.
Cytometry. Part B, Clinical Cytometry
|
July 16, 2020
A multicenter study evaluation of the ClearLLab 10C panels
Benjamin D Hedley, Guoyan Cheng, Michael Keeney, et al.
British Journal of Cancer
|
July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
T Golan, Z S Kanji, R Epelbaum, et al.
Cytometry. Part B, Clinical Cytometry
|
July 20, 2024
Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtain
Katherine A Devitt, Wolfgang Kern, Malgorzata A Kajstura, et al.
Lancet (London, England)
|
May 17, 1980
The place of bone-marrow transplantation in acute myelogenous leukaemia
R L Powles, G Morgenstern, H M Clink, et al.
Molecular Diagnosis & Therapy
|
April 6, 2022
Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies
Pratibha Bhai, Cyrus C Hsia, Laila C Schenkel, et al.
Cytometry. Part B, Clinical Cytometry
|
September 15, 2025
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel-recommendations and safeguards for clinical laboratories
Christopher J Groves, Michael A Linden, Ahmad Al-Attar, et al.
Current Oncology (Toronto, Ont.)
|
April 26, 2024
Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or <i>SF3B1</i> Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review
Shamim Mortuza, Benjamin Chin-Yee, Tyler E James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen
E Warner, D Hedley, I Andrulis, et al.
International Journal of Laboratory Hematology
|
October 29, 2021
Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?
Eri Kawata, Benjamin D Hedley, Benjamin Chin-Yee, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 97) with videos related to
Sort By:
Page
of 10
European Journal of Cancer (Oxford, England : 1990)
|
May 27, 2014
A phase II study of erlotinib in gemcitabine refractory advanced pancreatic cancer
D J Renouf, P A Tang, D Hedley, et al.
Cytometry. Part B, Clinical Cytometry
|
July 16, 2020
A multicenter study evaluation of the ClearLLab 10C panels
Benjamin D Hedley, Guoyan Cheng, Michael Keeney, et al.
British Journal of Cancer
|
July 30, 2014
Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers
T Golan, Z S Kanji, R Epelbaum, et al.
Cytometry. Part B, Clinical Cytometry
|
July 20, 2024
Implementation of flow cytometry testing on rare matrix samples: Special considerations and best practices when the sample is unique or difficult to obtain
Katherine A Devitt, Wolfgang Kern, Malgorzata A Kajstura, et al.
Lancet (London, England)
|
May 17, 1980
The place of bone-marrow transplantation in acute myelogenous leukaemia
R L Powles, G Morgenstern, H M Clink, et al.
Molecular Diagnosis & Therapy
|
April 6, 2022
Clinical Utility of Implementing a Frontline NGS-Based DNA and RNA Fusion Panel Test for Patients with Suspected Myeloid Malignancies
Pratibha Bhai, Cyrus C Hsia, Laila C Schenkel, et al.
Cytometry. Part B, Clinical Cytometry
|
September 15, 2025
Ad hoc antibody modification of a validated flow cytometric immunophenotyping panel-recommendations and safeguards for clinical laboratories
Christopher J Groves, Michael A Linden, Ahmad Al-Attar, et al.
Current Oncology (Toronto, Ont.)
|
April 26, 2024
Myelodysplastic Neoplasms (MDS) with Ring Sideroblasts or <i>SF3B1</i> Mutations: The Improved Clinical Utility of World Health Organization and International Consensus Classification 2022 Definitions, a Single-Centre Retrospective Chart Review
Shamim Mortuza, Benjamin Chin-Yee, Tyler E James, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 17, 1998
Phase II study of dexverapamil plus anthracycline in patients with metastatic breast cancer who have progressed on the same anthracycline regimen
E Warner, D Hedley, I Andrulis, et al.
International Journal of Laboratory Hematology
|
October 29, 2021
Reducing cytogenetic testing in the era of next generation sequencing: Are we choosing wisely?
Eri Kawata, Benjamin D Hedley, Benjamin Chin-Yee, et al.
Page
of 10